| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |